tiprankstipranks
Trending News
More News >
MindWalk Holdings (HYFT)
NASDAQ:HYFT
US Market
Advertisement

MindWalk Holdings (HYFT) Earnings Dates, Call Summary & Reports

Compare
402 Followers

Earnings Data

Report Date
Dec 11, 2025
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.04
Last Year’s EPS
-0.07
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Sep 15, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive outlook for MindWalk, driven by record revenue growth, improved financial health, and strategic advancements, including a successful rebranding and strengthening of their balance sheet. However, the presence of a net loss and ongoing restructuring challenges indicate areas for further improvement.
Company Guidance
During the earnings call for the first quarter of fiscal year 2026, MindWalk, formerly known as ImmunoPrecise Antibodies, reported robust financial performance metrics. The company achieved record revenue of $7.6 million, a 45% increase year-over-year, alongside gross profit of $4 million with an expanded margin of 53%. The operating loss narrowed to $2.7 million, while adjusted EBITDA loss improved significantly to $1.4 million from $2.8 million the previous year. Net loss also improved to $3 million. The company ended the quarter with $5 million in cash and received an additional $16.1 million in net proceeds from the divestiture of its Netherlands operations, which will now be classified as discontinued operations. Continued operations contributed $3.2 million in revenue, marking a 28% increase compared to the previous year. This financial backdrop supports MindWalk's strategic focus on its bio-native AI platform and rebranding efforts, with new initiatives like the dengue vaccine development and enhanced technology partnerships as key growth drivers moving forward.
Record Revenue Growth
MindWalk reported record revenue of $7.6 million for Q1 Fiscal 2026, up 45% year-over-year. Continued operations contributed $3.2 million in revenue, growing 28% year-over-year.
Improved Financial Metrics
Gross profit increased to $4 million with a margin of 53%, and adjusted EBITDA loss was halved to $1.4 million. Operating loss narrowed to $2.7 million, and net loss improved to $3 million.
Strategic Divestiture
The divestiture of Netherlands operations generated $16.1 million in net proceeds, strengthening the balance sheet and allowing concentration on high-margin initiatives.
Successful Rebranding
Transitioned to a unified brand identity under MindWalk, shifting from services to a bio-native AI platform model, and introduced new NASDAQ ticker HYFT.
BioIntelligence Ecosystem
Advanced BioIntelligence ecosystem integrating bio-native AI with over 15 molecules accepted into clinical trials and a 98% success rate in B-cell technology.

MindWalk Holdings (HYFT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

HYFT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Dec 11, 2025
2026 (Q2)
-0.04 / -
-0.065
Sep 15, 2025
2026 (Q1)
-0.04 / -0.07
-0.10940.00% (+0.04)
Jul 29, 2025
2025 (Q4)
-0.04 / -0.04
-0.52493.06% (+0.49)
Mar 28, 2025
2025 (Q3)
-0.06 / -0.48
-0.08-500.00% (-0.40)
Dec 10, 2024
2025 (Q2)
-0.07 / -0.07
-0.07310.00% (<+0.01)
Sep 16, 2024
2025 (Q1)
-0.08 / -0.11
-0.102-7.14% (>-0.01)
Jul 29, 2024
2024 (Q4)
-0.08 / -0.52
-0.145-260.00% (-0.38)
Mar 14, 2024
2024 (Q3)
-0.07 / -0.08
-0.13842.11% (+0.06)
Dec 14, 2023
2024 (Q2)
-0.09 / -0.07
-0.21866.67% (+0.15)
Sep 14, 2023
2024 (Q1)
-0.15 / -0.10
-0.27663.16% (+0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

HYFT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Sep 15, 2025
$2.21$1.76-20.36%
Jul 29, 2025
$2.02$1.72-14.85%
Mar 28, 2025
$0.44$0.39-11.36%
Dec 10, 2024
$0.42$0.40-4.76%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MindWalk Holdings (HYFT) report earnings?
MindWalk Holdings (HYFT) is schdueled to report earning on Dec 11, 2025, TBA (Confirmed).
    What is MindWalk Holdings (HYFT) earnings time?
    MindWalk Holdings (HYFT) earnings time is at Dec 11, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is HYFT EPS forecast?
          HYFT EPS forecast for the fiscal quarter 2026 (Q2) is -0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis